Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases

A review

Yusuke Matoba, Kouji Banno, Iori Kisu, Daisuke Aoki

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Introduction: Several types of photosensitizers such as 5-aminolevulinic acid are progenitors of protoporphyrin IX (PpIX). PpIX accumulates in cancer cells and has photosensitivity. Based on these characteristics, they are used in photodynamic diagnosis (PDD) and photodynamic therapy (PDT). These methods have recently been applied to gynecologic malignant diseases. Here, we review articles on clinical applications of PDD and PDT for these diseases. Materials and Methods: A systematic literature search in Pubmed was performed with a combination of keywords to collect the articles. Result: There were eight articles on PDT for uterine cervical diseases, including one study that included patients with cervical cancer. The disease remission rate ranged from 31.6% to 100%. PDD under hysteroscopy had positive effects on endometrial cancer, endometrial hyperplasia and secretory endometrial tissue, and 7 of 11 patients were able to become pregnant after PDT for endometrial cancer. For ovarian cancer, the sensitivity and specificity of clinical PDD were high. Discussion: There is a need to improve the disease remission rate in uterine cervical diseases, and application of PDT for cervical cancer should be considered. For endometrial cancer, the risks and benefits of PDD that should be compared with those of hysteroscopy using narrow band imaging, which already has been shown to have high efficacy and few side effects. For ovarian cancer, it will be necessary to collect more data to evaluate the effect of PDD on overall survival. Conclusion: PDD and PDT can contribute to diagnosis and therapy in clinical practice for gynecologic malignant diseases.

Original languageEnglish
Pages (from-to)52-57
Number of pages6
JournalPhotodiagnosis and Photodynamic Therapy
Volume24
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Female Genital Diseases
Photochemotherapy
Uterine Cervical Diseases
Endometrial Neoplasms
Hysteroscopy
Uterine Cervical Neoplasms
Ovarian Neoplasms
Narrow Band Imaging
Endometrial Hyperplasia
Aminolevulinic Acid
Photosensitizing Agents
PubMed
Sensitivity and Specificity

Keywords

  • 5-Aminolevulinic acid
  • Cervical cancer
  • Endometrial cancer
  • Ovarian cancer
  • Photodynamic diagnosis
  • Photodynamic therapy

ASJC Scopus subject areas

  • Biophysics
  • Oncology
  • Dermatology
  • Pharmacology (medical)

Cite this

Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases : A review. / Matoba, Yusuke; Banno, Kouji; Kisu, Iori; Aoki, Daisuke.

In: Photodiagnosis and Photodynamic Therapy, Vol. 24, 01.12.2018, p. 52-57.

Research output: Contribution to journalReview article

@article{48d2c34f12324488a8769d593ace2f48,
title = "Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases: A review",
abstract = "Introduction: Several types of photosensitizers such as 5-aminolevulinic acid are progenitors of protoporphyrin IX (PpIX). PpIX accumulates in cancer cells and has photosensitivity. Based on these characteristics, they are used in photodynamic diagnosis (PDD) and photodynamic therapy (PDT). These methods have recently been applied to gynecologic malignant diseases. Here, we review articles on clinical applications of PDD and PDT for these diseases. Materials and Methods: A systematic literature search in Pubmed was performed with a combination of keywords to collect the articles. Result: There were eight articles on PDT for uterine cervical diseases, including one study that included patients with cervical cancer. The disease remission rate ranged from 31.6{\%} to 100{\%}. PDD under hysteroscopy had positive effects on endometrial cancer, endometrial hyperplasia and secretory endometrial tissue, and 7 of 11 patients were able to become pregnant after PDT for endometrial cancer. For ovarian cancer, the sensitivity and specificity of clinical PDD were high. Discussion: There is a need to improve the disease remission rate in uterine cervical diseases, and application of PDT for cervical cancer should be considered. For endometrial cancer, the risks and benefits of PDD that should be compared with those of hysteroscopy using narrow band imaging, which already has been shown to have high efficacy and few side effects. For ovarian cancer, it will be necessary to collect more data to evaluate the effect of PDD on overall survival. Conclusion: PDD and PDT can contribute to diagnosis and therapy in clinical practice for gynecologic malignant diseases.",
keywords = "5-Aminolevulinic acid, Cervical cancer, Endometrial cancer, Ovarian cancer, Photodynamic diagnosis, Photodynamic therapy",
author = "Yusuke Matoba and Kouji Banno and Iori Kisu and Daisuke Aoki",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.pdpdt.2018.08.014",
language = "English",
volume = "24",
pages = "52--57",
journal = "Photodiagnosis and Photodynamic Therapy",
issn = "1572-1000",
publisher = "Elsevier",

}

TY - JOUR

T1 - Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases

T2 - A review

AU - Matoba, Yusuke

AU - Banno, Kouji

AU - Kisu, Iori

AU - Aoki, Daisuke

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Introduction: Several types of photosensitizers such as 5-aminolevulinic acid are progenitors of protoporphyrin IX (PpIX). PpIX accumulates in cancer cells and has photosensitivity. Based on these characteristics, they are used in photodynamic diagnosis (PDD) and photodynamic therapy (PDT). These methods have recently been applied to gynecologic malignant diseases. Here, we review articles on clinical applications of PDD and PDT for these diseases. Materials and Methods: A systematic literature search in Pubmed was performed with a combination of keywords to collect the articles. Result: There were eight articles on PDT for uterine cervical diseases, including one study that included patients with cervical cancer. The disease remission rate ranged from 31.6% to 100%. PDD under hysteroscopy had positive effects on endometrial cancer, endometrial hyperplasia and secretory endometrial tissue, and 7 of 11 patients were able to become pregnant after PDT for endometrial cancer. For ovarian cancer, the sensitivity and specificity of clinical PDD were high. Discussion: There is a need to improve the disease remission rate in uterine cervical diseases, and application of PDT for cervical cancer should be considered. For endometrial cancer, the risks and benefits of PDD that should be compared with those of hysteroscopy using narrow band imaging, which already has been shown to have high efficacy and few side effects. For ovarian cancer, it will be necessary to collect more data to evaluate the effect of PDD on overall survival. Conclusion: PDD and PDT can contribute to diagnosis and therapy in clinical practice for gynecologic malignant diseases.

AB - Introduction: Several types of photosensitizers such as 5-aminolevulinic acid are progenitors of protoporphyrin IX (PpIX). PpIX accumulates in cancer cells and has photosensitivity. Based on these characteristics, they are used in photodynamic diagnosis (PDD) and photodynamic therapy (PDT). These methods have recently been applied to gynecologic malignant diseases. Here, we review articles on clinical applications of PDD and PDT for these diseases. Materials and Methods: A systematic literature search in Pubmed was performed with a combination of keywords to collect the articles. Result: There were eight articles on PDT for uterine cervical diseases, including one study that included patients with cervical cancer. The disease remission rate ranged from 31.6% to 100%. PDD under hysteroscopy had positive effects on endometrial cancer, endometrial hyperplasia and secretory endometrial tissue, and 7 of 11 patients were able to become pregnant after PDT for endometrial cancer. For ovarian cancer, the sensitivity and specificity of clinical PDD were high. Discussion: There is a need to improve the disease remission rate in uterine cervical diseases, and application of PDT for cervical cancer should be considered. For endometrial cancer, the risks and benefits of PDD that should be compared with those of hysteroscopy using narrow band imaging, which already has been shown to have high efficacy and few side effects. For ovarian cancer, it will be necessary to collect more data to evaluate the effect of PDD on overall survival. Conclusion: PDD and PDT can contribute to diagnosis and therapy in clinical practice for gynecologic malignant diseases.

KW - 5-Aminolevulinic acid

KW - Cervical cancer

KW - Endometrial cancer

KW - Ovarian cancer

KW - Photodynamic diagnosis

KW - Photodynamic therapy

UR - http://www.scopus.com/inward/record.url?scp=85052934919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052934919&partnerID=8YFLogxK

U2 - 10.1016/j.pdpdt.2018.08.014

DO - 10.1016/j.pdpdt.2018.08.014

M3 - Review article

VL - 24

SP - 52

EP - 57

JO - Photodiagnosis and Photodynamic Therapy

JF - Photodiagnosis and Photodynamic Therapy

SN - 1572-1000

ER -